VEGFA and Chagas disease: We recognize the high cost of the antibody and the consequent difficulty of its broad use as a treatment for Chagas disease; however, once the participation of VEGF is demonstrated, we hope that it will provoke the investigation of low-cost and accessible inhibitors.